Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL107551 | 0.98 | HRH3 (0.34) | HRH3GPR84 | |
| Water SCHEMBL1176980 | 0.96 | HRH3 (0.33) | HRH3GPR84 | |
| Fluoride Ion SCHEMBL5046809 | 0.96 | HRH3 (0.33) | HRH3GPR84 | |
| SCHEMBL8003081 | 0.96 | HRH3 (0.33) | HRH3GPR84 | |
| Hydrochloric Acid SCHEMBL193045 | 0.96 | HRH3 (0.33) | HRH3SMN1; SMN2GPR84 | |
| Bromide SCHEMBL193081 | 0.96 | HRH3 (0.33) | HRH3NPC1LMNAHTTRAB9A | |
| Hydrochloric Acid SCHEMBL2831078 | 0.94 | HRH3 (0.32) | HRH3SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL1782212 | 0.94 | HRH3 (0.32) | HRH3SMN1; SMN2 | |
| Iodide SCHEMBL4339390 | 0.94 | KCNH2 (0.36) | HRH3KDM4ENPC1LMNAHTT | |
| Bromide SCHEMBL15532008 | 0.94 | HRH3 (0.32) | HRH3NPC1LMNAHTTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3316998-A1 | COMPOSITE MEMBRANES WITH IMPROVED PERFORMANCE AND/OR DURABILITY AND METHODS OF USE | 3M Innovative Properties Company (US) | 2018-05-09 | — | — | EP | claimed |
| WO-2017004495-A1 | COMPOSITE MEMBRANES WITH IMPROVED PERFORMANCE AND/OR DURABILITY AND METHODS OF USE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-01-05 | — | — | WO | claimed |
| WO-2014090960-A1 | IMPROVED SOLAR CELL | SOLARPRINT LIMITED (IE) | 2014-06-19 | — | — | WO | claimed |
| US-20140034869-A1 | Gel Electrolytes For Dye Sensitized Solar Cells | MERCK PATENT GMBH (DE) | 2014-02-06 | — | — | US | claimed |
| US-8581096-B2 | Gel electrolytes for dye sensitized solar cells | MERCK PATENT GMBH (DE) | 2013-11-12 | — | — | US | claimed |
| US-8236974-B2 | Process for preparing glycidyl esters | BASF SE (DE) | 2012-08-07 | — | — | US | claimed |
| US-20090272934-A1 | GEL ELECTROLYTES FOR DYE SENSITIZED SOLAR CELLS | MERCK KGAA (DE) | 2009-11-05 | — | — | US | claimed |
| EP-1663921-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-07 | — | — | EP | claimed |
| JP-2005516365-A | — | — | 2005-06-02 | — | — | JP | claimed |
| US-6900382-B2 | Gel electrolytes for dye sensitized solar cells | KONARKA TECHNOLOGIES, INC. (US) | 2005-05-31 | — | — | US | claimed |
| WO-2005026089-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-24 | — | — | WO | claimed |
| US-20050039790-A1 | Gel electrolytes for dye sensitized solar cells | KONARKA TECHNOLOGIES, INC. (US) | 2005-02-24 | — | — | US | claimed |
| EP-1470563-A2 | PHOTOVOLTAIC CELL COMPONENTS AND MATERIALS | Konarka Technologies, Inc. (US) | 2004-10-27 | — | — | EP | claimed |
| US-20040025933-A1 | Gel electrolytes for dye sensitized solar cells | KONARKA TECHNOLOGIES, INC. (US) | 2004-02-12 | — | — | US | claimed |
| WO-2003065394-A2 | PHOTOVOLTAIC CELL COMPONENTS AND MATERIALS | KONARKA TECHNOLOGIES, INC. (US) | 2003-08-07 | — | — | WO | claimed |
| US-12540199-B2 | Molding material production method and molding material | SEIKO EPSON CORPORATION (JP) | 2026-02-03 | — | — | US | disclosed |
| WO-2025128597-A1 | USE OF PERFLUOROALKYL SUBSTANCE-FREE HEAT TRANSFER FLUIDS IN SUBSTRATE PROCESSING TOOLS | LAM RESEARCH CORPORATION (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2003065471-A2 | PHOTOVOLTAIC FIBERS | KONARKA TECHNOLOGIES, INC. (US) | 2003-08-07 | — | — | WO | disclosed |
| WO-2003065472-A2 | STRUCTURES AND MATERIALS FOR DYE SENSITIZED SOLAR CELLS | KONARKA TECHNOLOGIES, INC. (US) | 2003-08-07 | — | — | WO | disclosed |
| WO-2003065394-A2 | PHOTOVOLTAIC CELL COMPONENTS AND MATERIALS | KONARKA TECHNOLOGIES, INC. (US) | 2003-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540199-B2 | Molding material production method and molding material | ACP1, RPL28, PLIN3 | HRH3 1090/4885KDM4E 632/4885NPC1 3501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.